NASDAQ:CNAT
Delisted

Conatus Pharmaceuticals Inc. Stock Price (Quote)

$0.255
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.255 $0.255 Friday, 27th May 2022 CNAT stock ended at $0.255. During the day the stock fluctuated 0% from a day low at $0.255 to a day high of $0.255.
90 days $0.238 $0.275
52 weeks $0.203 $1.23

Historical Conatus Pharmaceuticals Inc. prices

Date Open High Low Close Volume
2019-05-02 $0.85 $0.86 $0.81 $0.85 193 328
2019-05-01 $0.85 $0.87 $0.770 $0.83 464 789
2019-04-30 $0.89 $0.89 $0.80 $0.86 1 096 838
2019-04-29 $0.770 $0.85 $0.770 $0.82 595 443
2019-04-26 $0.755 $0.797 $0.720 $0.773 415 739
2019-04-25 $0.82 $0.82 $0.755 $0.768 333 515
2019-04-24 $0.784 $0.84 $0.760 $0.81 651 362
2019-04-23 $0.750 $0.783 $0.750 $0.779 288 249
2019-04-22 $0.85 $0.87 $0.741 $0.750 1 133 894
2019-04-18 $0.720 $0.92 $0.710 $0.83 2 624 833
2019-04-17 $0.770 $0.770 $0.687 $0.710 1 852 627
2019-04-16 $0.83 $0.84 $0.750 $0.770 1 042 819
2019-04-15 $1.21 $1.21 $0.730 $0.80 5 692 398
2019-04-12 $1.27 $1.27 $1.19 $1.22 1 246 478
2019-04-11 $1.35 $1.36 $1.23 $1.26 1 245 598
2019-04-10 $1.29 $1.39 $1.25 $1.33 1 655 363
2019-04-09 $1.30 $1.32 $1.27 $1.29 464 209
2019-04-08 $1.25 $1.35 $1.25 $1.30 832 449
2019-04-05 $1.30 $1.33 $1.25 $1.25 694 695
2019-04-04 $1.36 $1.37 $1.22 $1.30 934 261
2019-04-03 $1.36 $1.44 $1.28 $1.33 1 642 245
2019-04-02 $1.16 $1.37 $1.16 $1.36 2 214 005
2019-04-01 $1.08 $1.25 $1.08 $1.16 1 162 731
2019-03-29 $1.12 $1.13 $1.08 $1.08 618 109
2019-03-28 $1.14 $1.17 $1.10 $1.11 507 531
Click to get the best stock tips daily for free!

About Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals. Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. Its product candidates include Emricasan, an orally active pan-caspase protease inhibitor that is in Phase II clinical trials for the treatment of liver cirrhosis, acute-on-chronic liver failure, post-orthotopic liver transplant as a result of hepatitis C virus infection with sust... CNAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT